Diversity and Epidemiology of Mokola Virus

PLoS Neglected Tropical Diseases

Volumn 7, Issue 10, 2013, Pages

  Kgaladi, Joe ^a   Wright, Nicolette ^a   Coertse, Jessica ^a   Markotter, Wanda ^a   Marston, Denise ^b   Fooks, Anthony R ^b,c   Freuling, Conrad M ^d   Müller, Thomas F ^d   Sabeta, Claude T ^e   Nel, Louis H ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^e ONDERSTEPOORT VETERINARY INSTITUTE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENE SEQUENCE; MICROBIAL DIVERSITY; MOKOLA VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PYROSEQUENCING; RABIES VIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; UNINDEXED SEQUENCE; VIRUS ISOLATION;

AFRICA, SOUTHERN; ANIMALS; CLUSTER ANALYSIS; GENETIC VARIATION; HUMANS; LYSSAVIRUS; MOLECULAR SEQUENCE DATA; PHYLOGENY; RHABDOVIRIDAE INFECTIONS; SEQUENCE ANALYSIS, DNA; VIRAL PROTEINS;

EID: 84887305142     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002511     Document Type: Article

References (71)

1. Dietzgen RG, Calisher CH, Kurath G, Kuzmin IV, Rodriguez LL, et al.(2012) Family Rhabdoviridae. In: A.M.Q. King, M.J. Adams, E.B. Carstens and E.J. Lefkowitz (Eds), Virus taxonomy: classification and nomenclature of viruses- Ninth Report of the International Committee on Taxonomy of Viruses, pp. 686-713. Elsevier, San Diego.
2. Banyard AC, Hayman D, Johnson N, McElhinney LM, Fooks AR, (2011) Bats and Lyssaviruses. Adv Virus Res 79: 239-289.
3. Kuzmin IV, Mayer AE, Niezgoda M, Markotter W, Agwanda B, et al. (2010) Shimoni bat virus, a new representative of the lyssavirus genus. Virus Res 149: 197-210.
4. Marston DA, Horton DL, Ngeleja C, Hampson K, McElhinney LM, et al. (2012) Ikoma lyssavirus, Highly Divergent Novel Lyssavirus in an African Civet. Emerg Infect Dis 18: 664-667.
5. Aitken THG, Kowalski RW, Beaty BJ, Buckley SM, Wright JD, et al. (1984) Arthropod studies with rabies-related Mokola virus. Am J Trop Med Hyg 33: 945-952.
6. Kemp GE, Causey OR, Moore DL, Odelola A, Fabiyi A, (1972) Mokola virus: Further studies on IbAn 27377, a new rabies-related etiological agent of zoonosis in Nigeria. Am J Trop Med Hyg 21: 356-359.
7. Shope RE, Murphy FA, Harrison AK, Causey OR, Kemp GE, et al. (1970) Two African viruses serologically and morphologically related to rabies virus. J Virol 6: 690-692.
8. Familusi JB, Osunkoya BO, Moore DL, Kemp GE, Fabiyi A, (1972) A fatal human infection with Mokola virus. Am J Trop Med Hyg 21: 959-963.
9. Familusi JB, Moore DL, (1972) Isolation of a rabies-related virus from the cerebrospinal fluid of a child with 'aseptic meningitis. Afr J Med Sci 3: 93-96.
10. Le Gonidec G, Rickenbach A, Robin Y, Heme G, (1978) Isolation of a strain of Mokola virus in Cameroon. Annu Microbiol 129: 245-249.
11. Saluzzo JF, Rollin PE, Dauguet C, Digoutte JP, Georges AJ, et al. (1984) Premier isolment du virus Mokola a partir D'un rongeur (Lophuromys sikapusi). Ann Inst Pasteur Virol 135: 57-66.
12. Foggin CM, (1982) Atypical rabies virus in cats and a dog in Zimbabwe. Vet Rec 110: 338.
13. Foggin CM (1988) Rabies and rabies-related viruses in Zimbabwe: Historical, virological and ecological aspects. PhD thesis. Harare: University of Zimbabwe.
14. Mebatsion T, Cox JH, Frost JW, (1992) Isolation and characterisation of 115 street rabies virus isolates from Ethiopia by using monoclonal antibodies: identification of 2 isolates of Mokola and Lagos Bat viruses. J Infect Dis 166: 972-977.
15. Bingham J, Javangwe S, Sabeta CT, Wandeler AI, Nel LH, (2001) Report of isolations of unusual lyssaviruses (rabies and Mokola virus) identified retrospectively from Zimbabwe. J S Afr Vet Assoc 72: 92-94.
16. Schneider LG, Barnard BJH, Schneider HP (1985) Application of monoclonal antibodies for epidemiological investigations and oral vaccination studies I-African viruses. In: "Rabies in the Tropics" pp. 47-59. Edited by EKuwert & CMerieux. Berlin: Springer Verlag.
17. Meredith CD, Nel LH, Von Teichman BF, (1996) Further isolation of Mokola virus in South Africa. Vet Rec 138: 119-120.
18. Nel LH, Jacobs J, Jafta J, von Teichman B, Bingham J, (2000) New cases of Mokola virus in South Africa. Virus Genes 20: 103-106.
19. Von Teichman BF, De Koker WC, Bosch SJ, Bishop GC, Meredith CD, et al. (1998) Mokola virus infection: description of recent South African cases and a review of the virus epidemiology. J S Afr Vet Assoc 69: 169-171.
20. Sabeta CT, Makotter W, Mohale DK, Shumba W, Wandeler AI, et al. (2007) Mokola virus in domestic mammals, South Africa. Emerg Infect Dis 13: 1371-1373.
21. Sabeta C, Blumberg L, Miyen J, Mohale D, Shumba W, et al. (2010) Mokola virus involved in a human contact (South Africa). FEMS Immunol Med Microbiol 58: 85-90.
22. Brookes SM, Parsons G, Johnson N, McElhinney LM, Fooks AR, (2005) Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses. Vaccine 23: 4101-4109.
23. Hooper PT, Lunt RA, Gould AR, Samaratunga H, Hyatt AD, et al. (1997) A new lyssavirus- the first endemic rabies-related virus recognized in Australia. Bull Institut Pasteur 95: 209-218.
24. Jallet C, Jacob Y, Bahloul C, Drings A, Desmezieres E, et al. (1999) Chimeric lyssavirus glycoprotein genes with increased immunological potential. J Virol 73: 225-233.
25. Lafon M, Bourhy H, Sureau P, (1988) Immunity against the European bat rabies (Duvenhage) virus induced by rabies vaccines: an experimental study in mice. Vaccine 6: 362-368.
26. Malerczyk C, Selhorst T, Tordo N, Moore S, Müller T, (2009) Antibodies induced by vaccination with purified chick embryo cell culture vaccine (PCECV) cross-neutralize non-classical bat lyssavirus strains. Vaccine 27: 5320-5325.
27. Bahloul C, Jacob Y, Tordo N, Perrin P, (1998) DNA-based immunization for exploring the enlargement of immunological cross-reactivity against the lyssaviruses. Vaccine 16: 417-425.
28. Fekadu M, Shaddock JK, Sanderlin DW, Smith JS, (1988) Efficacy of rabies vaccines against Duvenhage virus isolated from European house bats (Eptesicus serotinus), classic rabies and rabies-related viruses. Vaccine 6: 533-539.
29. Fooks AR, (2004) The challenge of emerging lyssaviruses. Expert Rev Vaccines 4: 89-92.
30. Le Mercier P, Jacob Y, Tordo N, (1997) The complete Mokola virus genome sequence: structure of the RNA-dependent RNA polymerase. J Gen Virol 78: 1571-1576.
31. Nel LH, Niezgoda M, Hanlon CA, Morril PA, Yager PA, et al. (2003) A comparison of DNA vaccines for the rabies-related virus, Mokola. Vaccine 21: 2598-2606.
32. Nel LH, (2005) Vaccines for lyssaviruses other than rabies. Expert Rev Vaccines 4: 533-540.
33. Sabeta CT (2002) Aspects of the molecular epidemiology of rabies in Zimbabwe and South Africa. PhD thesis. Pretoria: University of Pretoria, South Africa.
34. Van Zyl N (2009) Molecular epidemiology of African mongoose rabies and Mokola virus. MSc thesis. Pretoria: University of Pretoria, South Africa.
35. Van Zyl N, Markotter W, Nel LH, (2010) Evolutionary history of African mongoose rabies. Virus Res 150: 93-102.
36. Hayman DT, Johnson N, Horton DL, Hedge J, Wakeley PR, et al. (2011) Evolutionary history of rabies in Ghana. PLoS Negl Trop Dis 5: e1001 doi:10.1371/journal.pntd.0001001.
37. Hughes GJ, Orciari LA, Rupprecht CE, (2005) Evolutionary timescale of rabies virus adaptation to North American bats inferred from the substitution rate of the nucleoprotein Gene. J Gen Virol 86: 1467-1474.
38. McElhinney LM, Marston D, Freuling CM, Cragg WJ, Stankov S, et al. (2011) Molecular diversity and evolutionary history of rabies virus strains circulating in the Balkans. J GenVirol 92: 2171-2180.
39. Ming P, Yan J, Rayner S, Meng S, Xu G, et al. (2010) A history estimate and evolutionary analysis of rabies virus variants in China. J Gen Virol 91: 759-764.
40. Talbi C, Holmes EC, de Benedictis P, Faye O, Nakoune E, et al. (2009) Evolutionary history and dynamics of dog rabies virus in western and central Africa. J Gen Virol 90: 783-791.
41. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28: 2731-2739.
42. Drummond AJ, Suchard MA, Xie D, Rambaunt A, (2012) Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol 29: 1969-1973.
43. Drummond AJ, Ho SYW, Phillips MJ, Rambaut A, (2006) Relaxed phyloegenetics and dating with confidence. PLoS Biol 4: e88 doi:10.1371/journal.pbio.0040088.
44. Drummond AJ, Nicholis GK, Rodrigo AG, Solomon W, (2002) Estimating mutation parameters, population history and genealogy simultaneously from temporally spaced sequence data. Genetics 161: 1307-1320.
45. Badrane H, Bahloul C, Perrin P, Tordo N, (2001) Evidence of two phylogroup with distinct pathogenicity and immunogenicity. J Virol 75: 3268-3276.
46. Badrane H, Tordo N, (2001) Host switching in the Lyssavirus history from the Chiroptera to Carnivora orders. J Virol 17: 8096-8014.
47. Bourhy H, Reynes J, Dunham EJ, Dacheux L, Larrous F, et al. (2008) The origin and phylogeography of dog rabies virus. J Gen Virol 89: 2673-2681.
48. Holmes EC, Woelk CH, Kassis R, Bourhy H, (2002) Genetic constraints and the adaptive evolution of rabies virus in nature. Virology 292: 247-257.
49. Kgaladi J, Nel LH, Markotter W, (2013) Comparison of pathogenic domains of rabies and African rabiesrelated lyssaviruses and pathogenicity observed in mice. Onderstepoort J Vet Res 80doi: 10.4102/ojvr.v80i1.511.
50. Bourhy H, Kissi B, Tordo N, (1993) Molecular diversity of the lyssavirus genus. Virology 194: 70-81.
51. Kissi B, Tordo N, Bourhy H, (1995) Genetic polymorphism in the rabies virus nucleoprotein gene. Virology 209: 526-537.
52. Wertheim JO, Chu DKW, Peiris JSM, Pond SLK, Poon LLM, (2013) A Case for the Ancient Origin of Coronaviruses. J Virol 87: 7039-7045.
53. Wertheim JO, Pond SLK, (2011) Purifying Selection Can Obscure the Ancient Age of Viral Lineages. Mol Biol Evol 28: 3355-3365.
54. Dzikwi AA, Kuzmin IV, Umoh JU, Kwaga JKP, Ahmad AA, et al. (2010) Evidence of Lagos bat virus circulation among Nigerian fruit bats. J Wildl Dis 46: 267-271.
55. Kuzmin IV, Niezgoda M, Franka R, Agwanda B, Markotter W, et al. (2008) Lagos bat virus in Kenya. J Clin Microbiol 46: 1451-1461.
56. Wright E, Hayman DT, Vaughan A, Temperton NJ, Wood JL, et al. (2010) Virus neutralising activity of African fruit bat (Eidolon helvum) sera against emerging lyssaviruses. Virology 408: 183-189.
57. Hanlon CA, Kuzmin IV, Blanton JD, Weldon WC, Manangan JS, et al. (2005) Efficacy of rabies biologics against new lyssaviruses from Eurasia. Virus Res 111: 44-54.
58. Hayman DT, Fooks AR, Horton D, Suu-Ire R, Breed AC, et al. (2008) High-level antibody seroprevalence to Lagos bat virus detected in megachiroptera from West Africa. Emerg Infect Dis 14: 926-928.
59. Hayman DT, Fooks AR, Rowcliffe M, Restif O, Baker K, et al. (2012) Endemic Lagos bat virus infection in Eidolon helvum. Epidemiol Infect 140: 2163-2171.
60. Masatania T, Ito N, Shimizua K, Ito Y, Nakagawaa K, et al. (2011) Amino acids at positions 273 and 394 in rabies virus nucleoprotein are important for both evasion of host RIG-I mediated antiviral response and pathogenicity. Virus Res 155: 168-174.
61. Irie T, Carnero E, Okumura A, García-Sastre A, Harty RN, (2007) Modifications of the PSAP region of the matrix protein lead to attenuation of vesicular stomatitis virus in vitro and in vivo',. J Gen Virol 88: 2559-2567.
62. Wirblich C, Tan GS, Papaneri A, Godlewski PJ, Orenstein JM, et al. (2008) PPEY motif within the rabies virus (RV) matrix protein is essential for efficient virion release and RV pathogenicity. J Virol 82: 9730-9738.
63. Gholami A, Kassis R, Real E, Delmas O, Guadagnini S, et al. (2008) Mitochondrial dysfunction in lyssavirus-induced apoptosis',. J Virol 82: 4774-4784.
64. Mita T, Shimizu K, Ito N, Yamada K, Ito Y, et al. (2008) Amino acid at position 95 of the matrix protein is a cytopathic determinant of rabies virus. Virus Res 137: 33-39.
65. Faber M, Faber ML, Papaneri A, Bette M, Weihe E, et al. (2005) A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity. J Virol 79: 14141-14148.
66. Lentz TL, Wilson PT, Hawrot E, Speicher DW, (1984) Amino acid sequence similarity between rabies virus glycoprotein and snake venom curaremimetic neurotoxins. Science 226: 847-848.
67. Takayama-Ito M, Ito N, Yamadaa K, Sugiyama M, Minamoto N, (2006) Multiple amino acids in the glycoprotein of rabies virus are responsible for pathogenicity in adult mice. Virus Res 115: 169-175.
68. Langevin C, Tuffereau C, (2002) Mutations conferring resistance to neutralization by a soluble form of the neurotrophin receptor (p75NTR) map outside of the known antigenic sites of the rabies virus glycoprotein. J Virol 76: 10756-10765.
69. Tuffereau C, Leblois H, Bénéjean J, Coulon P, Lafay F, et al. (1989) Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice. Virology 172: 206-212.
70. Dietzschold B, Wunner WH, Wiktor TJ, Lopes AD, Lafon M, et al. (1983) 'Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc Natl Acad Sci U S A 80: 70-74.
71. Coulon P, Ternaux JP, Flamand A, Tuffereau C, (1998) An avirulent mutant of rabies virus is unable to infect motoneurons in vivo and in vitro. J Virol 7: 273-8.